Anthem Inc. (NYSE:ANTM) insider Joseph Swedish sold 24,513 shares of the firm’s stock in a transaction that occurred on Friday, November 11th. The shares were sold at an average price of $131.48, for a total value of $3,222,969.24. Following the completion of the transaction, the insider now directly owns 87,381 shares in the company, valued at $11,488,853.88. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Anthem Inc. (NYSE:ANTM) opened at 138.42 on Wednesday. The company has a market cap of $36.46 billion, a P/E ratio of 16.25 and a beta of 0.57. The firm has a 50-day moving average price of $124.49 and a 200 day moving average price of $129.29. Anthem Inc. has a 12 month low of $114.85 and a 12 month high of $148.00.

Anthem (NYSE:ANTM) last announced its earnings results on Wednesday, November 2nd. The company reported $2.45 earnings per share for the quarter, missing the Zacks’ consensus estimate of $2.47 by $0.02. The firm had revenue of $21.13 billion for the quarter, compared to the consensus estimate of $20.77 billion. Anthem had a return on equity of 11.64% and a net margin of 2.74%. Anthem’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the business posted $2.73 EPS. On average, equities analysts expect that Anthem Inc. will post $10.81 earnings per share for the current year.

Insider Buying and Selling by Quarter for Anthem (NYSE:ANTM)

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 21st. Stockholders of record on Monday, December 5th will be paid a dividend of $0.65 per share. The ex-dividend date of this dividend is Thursday, December 1st. This represents a $2.60 dividend on an annualized basis and a dividend yield of 1.88%. Anthem’s dividend payout ratio (DPR) is currently 30.52%.

Several research analysts have commented on ANTM shares. Cantor Fitzgerald set a $125.00 price target on Anthem and gave the stock a “hold” rating in a research report on Wednesday, November 2nd. Leerink Swann lifted their price target on Anthem from $155.00 to $160.00 and gave the stock an “outperform” rating in a research report on Thursday, November 3rd. Jefferies Group dropped their price target on Anthem from $157.00 to $156.00 and set a “buy” rating on the stock in a research report on Thursday, July 28th. Barclays PLC dropped their price target on Anthem from $158.00 to $151.00 and set an “equal weight” rating on the stock in a research report on Thursday, July 28th. Finally, Citigroup Inc. dropped their price target on Anthem from $172.00 to $162.00 and set a “buy” rating on the stock in a research report on Thursday, July 28th. Nine research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Anthem has an average rating of “Buy” and an average price target of $158.05.

Several institutional investors have recently made changes to their positions in the company. Ameritas Investment Partners Inc. raised its position in shares of Anthem by 21.0% in the third quarter. Ameritas Investment Partners Inc. now owns 6,291 shares of the company’s stock worth $788,000 after buying an additional 1,093 shares during the period. Verition Fund Management LLC raised its position in shares of Anthem by 26.9% in the third quarter. Verition Fund Management LLC now owns 49,364 shares of the company’s stock worth $6,186,000 after buying an additional 10,478 shares during the period. Candriam Luxembourg S.C.A. raised its position in shares of Anthem by 131.5% in the third quarter. Candriam Luxembourg S.C.A. now owns 93,155 shares of the company’s stock worth $11,673,000 after buying an additional 52,920 shares during the period. Lombard Odier Asset Management Europe Ltd purchased a new position in shares of Anthem during the third quarter worth $482,000. Finally, Dai Ichi Life Holdings Inc. raised its position in shares of Anthem by 3.3% in the third quarter. Dai Ichi Life Holdings Inc. now owns 13,565 shares of the company’s stock worth $1,700,000 after buying an additional 431 shares during the period. Institutional investors own 89.86% of the company’s stock.

Anthem Company Profile

Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.

5 Day Chart for NYSE:ANTM

Receive News & Stock Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related stocks with our FREE daily email newsletter.